GB0206462D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0206462D0
GB0206462D0 GB0206462A GB0206462A GB0206462D0 GB 0206462 D0 GB0206462 D0 GB 0206462D0 GB 0206462 A GB0206462 A GB 0206462A GB 0206462 A GB0206462 A GB 0206462A GB 0206462 D0 GB0206462 D0 GB 0206462D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0206462A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0206462A priority Critical patent/GB0206462D0/en
Publication of GB0206462D0 publication Critical patent/GB0206462D0/en
Priority to CNB028230876A priority patent/CN100392085C/en
Priority to US10/490,011 priority patent/US20070015721A1/en
Priority to AT02798748T priority patent/ATE506439T1/en
Priority to AU2002362368A priority patent/AU2002362368B2/en
Priority to EP10180900A priority patent/EP2322626A1/en
Priority to PL370359A priority patent/PL207168B1/en
Priority to NZ531814A priority patent/NZ531814A/en
Priority to DE60239815T priority patent/DE60239815D1/en
Priority to CA002461056A priority patent/CA2461056A1/en
Priority to BR0212619-2A priority patent/BR0212619A/en
Priority to PCT/EP2002/010592 priority patent/WO2003025003A2/en
Priority to JP2003528849A priority patent/JP4601956B2/en
Priority to MXPA04002631A priority patent/MXPA04002631A/en
Priority to IL16080902A priority patent/IL160809A0/en
Priority to KR1020047004128A priority patent/KR101067231B1/en
Priority to HU0402259A priority patent/HUP0402259A3/en
Priority to EP02798748A priority patent/EP1427826B1/en
Priority to TW091121625A priority patent/TWI329647B/en
Priority to MYPI20023515A priority patent/MY131949A/en
Priority to ARP020103561A priority patent/AR036566A1/en
Priority to CO04025208A priority patent/CO5560591A2/en
Priority to ZA2004/02189A priority patent/ZA200402189B/en
Priority to NO20041157A priority patent/NO331826B1/en
Priority to HK04109687.5A priority patent/HK1066830A1/en
Priority to US12/015,756 priority patent/US20090203144A1/en
Ceased legal-status Critical Current

Links

GB0206462A 2001-09-20 2002-03-19 Vaccines Ceased GB0206462D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GB0206462A GB0206462D0 (en) 2002-03-19 2002-03-19 Vaccines
EP02798748A EP1427826B1 (en) 2001-09-20 2002-09-18 HIV- RT-nef-Gag codon optimised DNA vaccines
JP2003528849A JP4601956B2 (en) 2001-09-20 2002-09-18 HIV-GAG codon optimized DNA vaccine
IL16080902A IL160809A0 (en) 2001-09-20 2002-09-18 HIV-gag CODON-OPTIMISED DNA VACCINES
AT02798748T ATE506439T1 (en) 2001-09-20 2002-09-18 CODONE-OPTIMIZED HIV-RT-NEF-GAG DNA VACCINES
AU2002362368A AU2002362368B2 (en) 2001-09-20 2002-09-18 HIV-gag codon-optimised DNA vaccines
EP10180900A EP2322626A1 (en) 2001-09-20 2002-09-18 HIV-GAG codon-optimised DNA vaccines
PL370359A PL207168B1 (en) 2001-09-20 2002-09-18 Vaccines
NZ531814A NZ531814A (en) 2001-09-20 2002-09-18 Vaccines
DE60239815T DE60239815D1 (en) 2001-09-20 2002-09-18 Codon-optimized HIV-RT nef-gag DNA vaccines
CA002461056A CA2461056A1 (en) 2001-09-20 2002-09-18 Hiv-gag codon-optimised dna vaccines
BR0212619-2A BR0212619A (en) 2001-09-20 2002-09-18 Nucleotide sequence, vector, protein, pharmaceutical composition, intradermal release device, method for treating a patient suffering from or susceptible to a disease, use of a nucleotide sequence, and process for the production of a nucleotide
PCT/EP2002/010592 WO2003025003A2 (en) 2001-09-20 2002-09-18 Hiv-gag codon-optimised dna vaccines
CNB028230876A CN100392085C (en) 2001-09-20 2002-09-18 Vaccines
MXPA04002631A MXPA04002631A (en) 2001-09-20 2002-09-18 Use of immidazoquinolinamines as adjuvants in dna vaccination.
US10/490,011 US20070015721A1 (en) 2001-09-20 2002-09-18 Hiv-gag codon-optimised dna vaccines
KR1020047004128A KR101067231B1 (en) 2001-09-20 2002-09-18 Hiv-gag codon-optimised dna vaccines
HU0402259A HUP0402259A3 (en) 2001-09-20 2002-09-18 Vaccines
ARP020103561A AR036566A1 (en) 2001-09-20 2002-09-20 VACCINES FOR HIV 1
TW091121625A TWI329647B (en) 2001-12-11 2002-09-20 Vaccines
MYPI20023515A MY131949A (en) 2001-09-20 2002-09-20 Vaccines
CO04025208A CO5560591A2 (en) 2001-09-20 2004-03-17 DNA VACCINES OPTIMIZED BY THE HIV-GAG CODON
ZA2004/02189A ZA200402189B (en) 2001-09-20 2004-03-18 Hiv-gag codon-optimised dna vaccines
NO20041157A NO331826B1 (en) 2001-09-20 2004-03-19 Nucleotide sequence, vector, protein, pharmaceutical preparation, intradermal delivery device, and method for producing a nucleotide sequence.
HK04109687.5A HK1066830A1 (en) 2001-09-20 2004-12-07 Hiv- rt-nef-gag codon optimised dna vaccines hiv-rt-nef-gag
US12/015,756 US20090203144A1 (en) 2001-09-20 2008-01-17 Hiv-gag codon-optimised dna vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0206462A GB0206462D0 (en) 2002-03-19 2002-03-19 Vaccines

Publications (1)

Publication Number Publication Date
GB0206462D0 true GB0206462D0 (en) 2002-05-01

Family

ID=9933282

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206462A Ceased GB0206462D0 (en) 2001-09-20 2002-03-19 Vaccines

Country Status (1)

Country Link
GB (1) GB0206462D0 (en)

Similar Documents

Publication Publication Date Title
GB0213622D0 (en) Vaccine Corporation
GB0202901D0 (en) Novel vaccine
GB0226722D0 (en) Vaccine
GB0225788D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0323840D0 (en) Vaccines
GB0218921D0 (en) Novel vaccine
GB0209878D0 (en) Vaccine
PL376534A1 (en) Vaccine
GB0321614D0 (en) Vaccines
AU2003237701A8 (en) Vaccines
GB0304634D0 (en) Vaccines
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0206462D0 (en) Vaccines
GB0217721D0 (en) Vaccines
GB0200829D0 (en) Vaccines
GB0206054D0 (en) Vaccine
GB0213364D0 (en) Vaccine
GB0230170D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)